These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8055457)

  • 1. Predictive parameters of biologic behavior of early stage nonseminomatous testicular germ cell tumors.
    de Riese WT; Albers P; Walker EB; Ulbright TM; Crabtree WN; Reister T; Foster RS; Donohue JP
    Cancer; 1994 Aug; 74(4):1335-41. PubMed ID: 8055457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive parameters in biologic assessment of low-stage retroperitoneal lymph-node dissection.
    Albers P; deRiese W; Walker EB; Ulbright TM; Crabtree WN; Reister T; Foster RS; Donohue JP
    World J Urol; 1994; 12(3):120-4. PubMed ID: 7951336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative DNA measurement by flow cytometry and image analysis of human nonseminomatous germ cell testicular tumors.
    de Riese W; Walker EB; de Riese C; Ulbright TM; Crabtree WN; Messemer J; Jones JA; Hinkel A; Foster RS; Donohue JP
    Urol Res; 1994; 22(4):213-20. PubMed ID: 7871632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor proliferative activity is predictive of pathological stage in clinical stage A nonseminomatous testicular germ cell tumors.
    Albers P; Ulbright TM; Albers J; Miller GA; Orazi A; Crabtree WN; Baniel J; Reister T; Sidner RA; Foster RS; Donohue JP
    J Urol; 1996 Feb; 155(2):579-86. PubMed ID: 8558664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical assessment of tumor proliferation and volume of embryonal carcinoma identify patients with clinical stage A nonseminomatous testicular germ cell tumor at low risk for occult metastasis.
    Albers P; Miller GA; Orazi A; Ulbright TM; Albers J; Donohue JP; Foster RS
    Cancer; 1995 Feb; 75(3):844-50. PubMed ID: 7828136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percentage of embryonal carcinoma and of vascular invasion predicts pathological stage in clinical stage I nonseminomatous testicular cancer.
    Moul JW; McCarthy WF; Fernandez EB; Sesterhenn IA
    Cancer Res; 1994 Jan; 54(2):362-4. PubMed ID: 8275469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow-cytometric and quantitative histologic parameters as prognostic indicators for occult retroperitoneal disease in clinical-stage-I non-seminomatous testicular germ-cell tumors.
    De Riese WT; De Riese C; Ulbright TM; Walker EB; Messemer J; Jones JA; Reister T; Albers P; Allhoff EP; Foster RS
    Int J Cancer; 1994 Jun; 57(5):628-33. PubMed ID: 8194868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simple model for predicting nodal metastasis in patients with clinical stage I nonseminomatous germ cell testicular tumors undergoing retroperitoneal lymph node dissection only.
    Nicolai N; Miceli R; Artusi R; Piva L; Pizzocaro G; Salvioni R
    J Urol; 2004 Jan; 171(1):172-6. PubMed ID: 14665870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis.
    Heidenreich A; Sesterhenn IA; Mostofi FK; Moul JW
    Cancer; 1998 Sep; 83(5):1002-11. PubMed ID: 9731905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of nuclear DNA ploidy pattern in nonseminomatous germ cell testicular tumors.
    Nativ O; Winkler HZ; Farrow GM; Therneau TM; Lieber MM
    Urology; 1994 Feb; 43(2):197-202. PubMed ID: 8116115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group.
    Heidenreich A; Albers P; Hartmann M; Kliesch S; Kohrmann KU; Krege S; Lossin P; Weissbach L;
    J Urol; 2003 May; 169(5):1710-4. PubMed ID: 12686815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MIB-1 immunohistochemistry in clinical stage I nonseminomatous testicular germ cell tumors predicts patients at low risk for metastasis.
    Albers P; Bierhoff E; Neu D; Fimmers R; Wernert N; Müller SC
    Cancer; 1997 May; 79(9):1710-6. PubMed ID: 9128986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometric and quantitative histological parameters to predict occult disease in clinical stage I nonseminomatous testicular germ cell tumors.
    Moul JW; Foley JP; Hitchcock CL; McCarthy WF; Sesterhenn IA; Becker RL; Griffin JL
    J Urol; 1993 Sep; 150(3):879-83. PubMed ID: 8393944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
    Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
    Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical expression of Ki-67 to predict lymph node involvement in clinical stage I nonseminomatous germ cell tumors.
    Heidenreich A; Schenkmann NS; Sesterhenn IA; Mostofi FK; McCarthy WF; Heidenreich B; Moul JW
    J Urol; 1997 Aug; 158(2):620-5. PubMed ID: 9224380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of primary tumor size and preorchiectomy serum tumor marker level in predicting pathologic stage at retroperitoneal lymph node dissection in clinical Stage A nonseminomatous germ cell tumors.
    Beck SD; Foster RS; Bihrle R; Donohue JP
    Urology; 2007 Mar; 69(3):557-9. PubMed ID: 17382165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: results of the German Testicular Cancer Study Group Trial.
    Albers P; Siener R; Kliesch S; Weissbach L; Krege S; Sparwasser C; Schulze H; Heidenreich A; de Riese W; Loy V; Bierhoff E; Wittekind C; Fimmers R; Hartmann M;
    J Clin Oncol; 2003 Apr; 21(8):1505-12. PubMed ID: 12697874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automated image analysis DNA cytometry to predict the pathological stage in clinical stage I nonseminomatous testicular germ cell tumors.
    Albers P; Burger RA; Braun MH; Fichtner J; Fisch M; Stöckle M
    Eur Urol; 1997; 31(3):356-9. PubMed ID: 9129931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical expression of P53 tumor suppressor gene protein in adult germ cell testis tumors: clinical correlation in stage I disease.
    Lewis DJ; Sesterhenn IA; McCarthy WF; Moul JW
    J Urol; 1994 Aug; 152(2 Pt 1):418-23. PubMed ID: 8015085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retroperitoneal lymph node dissection in patients with high risk testicular cancer.
    Williams SB; McDermott DW; Dock W; Bahnson E; Berry AM; Steele GS; Richie JP
    J Urol; 2009 May; 181(5):2097-101; discussion 2101-2. PubMed ID: 19286227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.